Harvard Apparatus Regenerative Technology, Inc. financial data

Symbol
HRGN on OTC
Location
84 October Hill Road, Suite 11, Holliston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Biostage, Inc. (to 7/10/2023)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 63.1 % -71.3%
Quick Ratio 3.36 %
Debt-to-equity 81.9 %
Return On Equity -751 % -155%
Return On Assets -302 % -51.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.5M shares +4.67%
Common Stock, Shares, Outstanding 14.3M shares +3.12%
Entity Public Float 33.8M USD -2.03%
Common Stock, Value, Issued 143K USD +2.88%
Weighted Average Number of Shares Outstanding, Basic 14.3M shares +3.43%
Weighted Average Number of Shares Outstanding, Diluted 14.3M shares +3.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 56K USD
Research and Development Expense 2.47M USD -22.6%
Selling and Marketing Expense 197K USD +258%
General and Administrative Expense 5.1M USD +63.6%
Operating Income (Loss) -7.95M USD +1.94%
Nonoperating Income (Expense) 45K USD -43.8%
Net Income (Loss) Attributable to Parent -7.97M USD +1.07%
Earnings Per Share, Basic -0.57 USD/shares +13.6%
Earnings Per Share, Diluted -0.57 USD/shares +13.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 139K USD -93.5%
Cash, Cash Equivalents, and Short-term Investments 100K USD -97.9%
Accounts Receivable, after Allowance for Credit Loss, Current 7K USD
Inventory, Net 60K USD
Other Assets, Current 51K USD +325%
Assets, Current 656K USD -86.9%
Property, Plant and Equipment, Net 14K USD -64.1%
Operating Lease, Right-of-Use Asset 68K USD +143%
Other Assets, Noncurrent 62K USD -64.2%
Assets 1.73M USD -70.1%
Accounts Payable, Current 752K USD +102%
Employee-related Liabilities, Current 156K USD +90.2%
Liabilities, Current 1.99M USD +1.27%
Operating Lease, Liability, Noncurrent 28K USD +55.6%
Liabilities 2.02M USD +1.76%
Accumulated Other Comprehensive Income (Loss), Net of Tax -22K USD
Retained Earnings (Accumulated Deficit) -96.5M USD -9%
Stockholders' Equity Attributable to Parent -290K USD -108%
Liabilities and Equity 1.73M USD -70.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -960K USD +5.23%
Net Cash Provided by (Used in) Financing Activities 801K USD -73.7%
Net Cash Provided by (Used in) Investing Activities -9K USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 14.3M shares +3.12%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.03M USD -20%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 432K USD -65.2%
Deferred Tax Assets, Valuation Allowance 23M USD -0.77%
Deferred Tax Assets, Gross 23M USD -0.88%
Operating Lease, Liability 68K USD +19.3%
Depreciation 6K USD -50%
Payments to Acquire Property, Plant, and Equipment 9K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.52M USD +3.52%
Lessee, Operating Lease, Liability, to be Paid 74K USD -48.6%
Property, Plant and Equipment, Gross 1.49M USD +0.75%
Operating Lease, Liability, Current 40K USD -66.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10K USD +100%
Lessee, Operating Lease, Liability, to be Paid, Year One 41K USD -40.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -39.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 19.2M USD -6.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 27K USD -10%
Additional Paid in Capital 96.1M USD +4.23%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 13K USD -67.5%
Share-based Payment Arrangement, Expense 572K USD +19.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares